RS
RSCF.US Reflect Scientific Inc
- Market cap
- USD 4.50M
- P/E
- -
- P/B
- 2.31x
- ROE
- 21.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is RSCF.US undervalued?
Graham numberThe Graham number of Reflect Scientific Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Reflect Scientific Inc fundamental analysis
No fundamental analysis for Reflect Scientific Inc yet.
Reflect Scientific Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Reflect Scientific Inc
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electroni…
Full company profileReflect Scientific Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Reflect Scientific Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.19M | 1.07M | 1.55M | 1.61M | 2.79M | 2.81M | 2.04M | 1.08M | 1.88M | 1.61M | 1.92M |
| Gross Profit | 813K | 660K | 1.06M | 992K | 1.72M | 1.93M | 1.22M | 596K | 558K | 559K | 879K |
| Operating Income | -252K | -402K | -249K | -195K | 651K | 828K | 90.1K | -467K | 131K | 167K | 521K |
| EBITDA | -211K | -402K | -246K | -191K | 713K | 885K | 146K | -406K | 242K | 247K | 610K |
| Net Income | -216K | -402K | -250K | -196K | 660K | 939K | 89.4K | -459K | 169K | 210K | 577K |
| EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | 0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 631K | 580K | 593K | 1.08M | 1.68M | 2.48M | 2.45M | 2.67M | 2.31M | 2.81M | 2.77M |
| Total Liabilities | 59.1K | 124K | 74.9K | 526K | 463K | 299K | 150K | 776K | 251K | 535K | 69.6K |
| Shareholders' Equity | 571K | 455K | 518K | 553K | 1.21M | 2.18M | 2.30M | 1.89M | 2.06M | 2.27M | 2.70M |
| Cash & Short-term Investments | 264K | 236K | 220K | 555K | 643K | 1.47M | 1.38M | 1.28M | 1.01M | 1.88M | 1.77M |
| Total Debt | - | - | 9.88K | 67.6K | 279K | 114K | 57.4K | 243K | 196K | 105K | 18.7K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -18.7K | -28.1K | -14.6K | 336K | -25.2K | 831K | -92.0K | -104K | - | - | 1.20M |
| Capital Expenditure | 10.8K | 10.8K | 10.8K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 14.00 |
| Free Cash Flow | -18.7K | -28.1K | -25.3K | 336K | -25.2K | 831K | -92.0K | -104K | - | - | 1.20M |
| Ratios | |||||||||||
| ROE | -37.8% | -88.3% | -48.2% | -35.5% | 54.4% | 43.1% | 3.9% | -24.3% | 8.2% | 9.2% | 21.3% |
| ROA | -34.3% | -69.4% | -42.1% | -18.2% | 39.4% | 37.9% | 3.7% | -17.2% | 7.3% | 7.5% | 20.8% |
| Net Profit Margin | -18.2% | -37.7% | -16.1% | -12.2% | 23.6% | 33.4% | 4.4% | -42.5% | 9.0% | 13.0% | 30.0% |
| Debt to Equity | - | - | 0.02x | 0.12x | 0.23x | 0.05x | 0.02x | 0.13x | 0.10x | 0.05x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Reflect Scientific Inc dividends
Reflect Scientific Inc has not paid dividends in the last 9 fiscal years.
Who owns Reflect Scientific Inc
Ownership data of Reflect Scientific Inc is not available yet.
Reflect Scientific Inc company profile
- Company name
- Reflect Scientific Inc
- Ticker
- RSCF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- Employees
- 7
- Fiscal year end
- December
- Address
- 1266 South 1380 West, Orem, UT, United States, 84058
- Phone
- 801 226 4100
- Website
- reflectscientific.com
About Reflect Scientific Inc
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.
Reflect Scientific Inc management
5- Mr. Kim BoyceFounder, Chairman, CEO, CFO & President · born 1955
- Mr. William Grant MoonVP of Engineering & Director · born 1950
- Mr. Thomas A. TaitVP, Secretary & Director · born 1957
- Mr. Eric PiersonManaging Director of Miralogix · born 1962
- Dr. Craig W. Morrison M.D.Chairman of Technical Advisory Board & Technical Advisor · born 1944